Azimuth Biologics was selected as one of 10 promising startup companies to participate in the BLUE KNIGHT™ QuickPitch: Activating for the Future event.
BLUE KNIGHT™ is a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.